VORVor Biopharma Inc.vs its industry peers
A metric-by-metric comparison of Vor Biopharma Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VOREsta | $1.3B#8 | 0.1x#1 | — | — | — | -495.3%#14 | — | — | — | — | -29.8%#2 | — |
| VIR | $1.8B#1 | — | 1.8x#1 | 25.8x#5 | -7.6%#8 | 16.1%#4 | -699.2%#5 | -44.6%#7 | — | — | — | — |
| RXRX | $1.7B#2 | — | 1.9x#2 | 23.2x#4 | 26.9%#5 | -39.1%#10 | -867.9%#6 | -70.5%#10 | -175.2%#3 | — | — | — |
| TSHA | $1.7B#3 | — | 4.3x#8 | 169.0x#7 | 17.3%#6 | -22.1%#7 | -1130.6%#7 | -28.1%#3 | — | — | — | — |
| INBX | $1.6B#4 | — | — | 1205.0x#8 | 550.0%#2 | -108.3%#12 | -10386.5%#9 | — | — | — | — | — |
| NVAX | $1.5B#5 | — | — | 1.4x#1 | 64.7%#3 | 334.8%#1 | 40.3%#1 | — | — | — | — | — |
| MAZE | $1.3B#6 | — | 3.0x#6 | 8.0x#2 | — | -351.0%#13 | -85.3%#3 | -28.9%#4 | -49.4%#2 | — | — | — |
| CGEM | $1.3B#7 | — | 3.2x#7 | — | -100.0%#10 | -31.2%#9 | — | -53.8%#9 | — | — | — | — |
| GLUE | $1.1B#10 | — | 2.3x#3 | 9.0x#3 | 63.5%#4 | 46.9%#2 | -43.8%#2 | -7.9%#2 | — | — | — | — |
| REPL | $1.2B#9 | — | 11.6x#11 | — | — | -26.9%#8 | — | -297.1%#12 | -7270.9%#4 | — | — | — |
| ODTX | $1.1B#11 | — | 2.5x#5 | — | — | — | — | 0.0%#1 | — | — | — | — |
| SANA | $949M#12 | — | 6.1x#9 | — | — | 8.5%#6 | — | -158.0%#11 | — | — | — | — |
| SLDB | $896M#13 | — | 2.4x#4 | 110.7x#6 | -40.6%#9 | -39.8%#11 | -2214.1%#8 | -46.6%#8 | — | — | — | — |
| CADL | $852M#14 | — | 6.8x#10 | 6813.2x#9 | 0.0%#7 | 30.8%#3 | -38612.8%#10 | -30.3%#5 | — | — | — | — |
| FDMT | — | — | — | — | 230194.6%#1 | 12.9%#5 | -187.2%#4 | -34.4%#6 | -44.7%#1 | — | 100.4%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice